123 related articles for article (PubMed ID: 1850701)
1. Carcinoembryonic proteins produced by Wilms' tumor cells in vitro and in vivo.
Ishiwata I; Ono I; Ishiwata C; Soma M; Nakaguchi T; Ohara K; Hirano M; Ishikawa H
Exp Pathol; 1991; 41(1):1-9. PubMed ID: 1850701
[TBL] [Abstract][Full Text] [Related]
2. The in vitro growth, heterotransplantation, and immunohistochemical characterization of the blastemal component of Wilms' tumor.
Garvin AJ; Sullivan JL; Bennett DD; Stanley WS; Inabnett T; Sens DA
Am J Pathol; 1987 Nov; 129(2):353-63. PubMed ID: 2445211
[TBL] [Abstract][Full Text] [Related]
3. Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line.
Hazen-Martin DJ; Re GG; Garvin AJ; Sens DA
Am J Pathol; 1994 May; 144(5):1023-34. PubMed ID: 8178926
[TBL] [Abstract][Full Text] [Related]
4. Production of platelet-derived growth factor by cultured Wilms' tumor cells and fetal kidney cells.
Fraizer GE; Bowen-Pope DF; Vogel AM
J Cell Physiol; 1987 Oct; 133(1):169-74. PubMed ID: 2444606
[TBL] [Abstract][Full Text] [Related]
5. The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney.
Garvin AJ; Re GG; Tarnowski BI; Hazen-Martin DJ; Sens DA
Am J Pathol; 1993 Feb; 142(2):375-80. PubMed ID: 8382007
[TBL] [Abstract][Full Text] [Related]
6. Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
Fukazawa I; Inaba N; Ota Y; Sato N; Shirotake S; Iwasawa H; Sekiya S; Takamizawa H; Suzuki N; Tokita H
Arch Gynecol Obstet; 1988; 243(2):69-81. PubMed ID: 3165255
[TBL] [Abstract][Full Text] [Related]
7. Wilms' tumor: a search for the critical lesion.
Wolman SR; Camuto PM; Eisenberg AJ; Feiner HD; Greco MA
Hum Pathol; 1990 Jul; 21(7):715-21. PubMed ID: 2163362
[TBL] [Abstract][Full Text] [Related]
8. Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma.
Dowdy SF; Weissman BE; Stanbridge EJ
J Cell Physiol; 1991 May; 147(2):248-55. PubMed ID: 1645741
[TBL] [Abstract][Full Text] [Related]
9. A nude mouse Wilms' tumor line (KCMC-WT-1) derived from an aniridia patient with monoalleleic partial deletion of chromosome 11p.
Nagashima Y; Nishihira H; Miyagi Y; Tanaka Y; Sasaki Y; Nishi T; Imaizumi K; Aoki I; Misugi K
Cancer; 1996 Feb; 77(4):799-804. PubMed ID: 8616775
[TBL] [Abstract][Full Text] [Related]
10. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of a human ovarian serous cystadenocarcinoma cell line that produces the tumor markers CA-125 and tissue polypeptide antigen.
Imai S; Kiyozuka Y; Maeda H; Noda T; Hosick HL
Oncology; 1990; 47(2):177-84. PubMed ID: 2314830
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and histologic findings in Wilms' tumor.
Gow KW; Murphy JJ
J Pediatr Surg; 2002 Jun; 37(6):823-7. PubMed ID: 12037743
[TBL] [Abstract][Full Text] [Related]
13. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression.
Weissman BE; Saxon PJ; Pasquale SR; Jones GR; Geiser AG; Stanbridge EJ
Science; 1987 Apr; 236(4798):175-80. PubMed ID: 3031816
[TBL] [Abstract][Full Text] [Related]
14. A cytogenetic study of Wilms' tumor.
Slater RM; de Kraker J; Voûte PA; Delemarre JF
Cancer Genet Cytogenet; 1985 Jan; 14(1-2):95-109. PubMed ID: 2981155
[TBL] [Abstract][Full Text] [Related]
15. [Establishment and characterization of a human ureteral cancer cell line producing carbohydrate antigen 19-9 and carcinoembryonic antigen].
Tanaka S; Iwasaki H; Nishida T; Watanabe R; Jouzaki H; Kikuchi M
Hum Cell; 1991 Mar; 4(1):44-50. PubMed ID: 1888704
[TBL] [Abstract][Full Text] [Related]
16. Molecular and cellular biology of Wilms' tumour.
Maitland NJ; Brown KW; Poirier V; Shaw AP; Williams J
Anticancer Res; 1989; 9(5):1417-26. PubMed ID: 2556071
[TBL] [Abstract][Full Text] [Related]
17. Discovery and identification of serum biomarkers of Wilms' tumor in mice using proteomics technology.
Jia ZK; Wang JX; Yang JJ; Xue R; Zhang D; Wang GN; Ma SL; Duan ZF
Chin Med J (Engl); 2012 May; 125(10):1727-32. PubMed ID: 22800891
[TBL] [Abstract][Full Text] [Related]
18. Human sarcomatous Wilms' tumor. Characterization with 5H10, a newly established monoclonal antibody.
Ishii E; Fujimoto J; Hara S; Tanaka S; Hata J
Acta Pathol Jpn; 1989 Oct; 39(10):656-63. PubMed ID: 2556005
[TBL] [Abstract][Full Text] [Related]
19. Induction of mouse tenascin expression by a human sarcomatoid Wilms' tumor cell line growing in nude mice.
Talts JF; Aufderheide E; Sorokin L; Ocklind G; Mattsson R; Ekblom P
Int J Cancer; 1993 Jul; 54(5):868-74. PubMed ID: 7686890
[TBL] [Abstract][Full Text] [Related]
20. Isochromosome 7q in adult Wilms' tumors: diagnostic and pathogenetic implications.
Rubin BP; Pins MR; Nielsen GP; Rosen S; Hsi BL; Fletcher JA; Renshaw AA
Am J Surg Pathol; 2000 Dec; 24(12):1663-9. PubMed ID: 11117788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
